A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma

A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma

10.1038/s41408-022-00768-5

Saved in:

Bibliographic Details
Main Authors:	Chng, WJ, Lonial, S, Morgan, GJ, Iida, S, Moreau, P, Kumar, SK, Twumasi-Ankrah, P, Villarreal, M, Dash, AB, Vorog, A, Zhang, X, Suryanarayan, K, Labotka, R, Dimopoulos, MA, Rajkumar, SV
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Springer Science and Business Media LLC 2023
Subjects:	Humans Multiple Myeloma Lenalidomide Dexamethasone Boron Compounds Chromosome Aberrations Antineoplastic Combined Chemotherapy Protocols
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/237477
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1038/s41408-022-00768-5